Leah Dickerson
Psychiatry · Jeffersonville, INNPI 1235291238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 675 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 675 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Vanda Pharmaceuticals Inc.$921
- Teva Pharmaceuticals USA, Inc.$710
- plus $3K from 15 others
What the payments were for
- Food & beverage$9,20198%
- Education$1762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 150 | $1,233 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 72 | $1,135 |
| Otsuka America Pharmaceutical, Inc. | 71 | $1,062 |
| Neurocrine Biosciences, Inc. | 79 | $1,046 |
| Vanda Pharmaceuticals Inc. | 49 | $921 |
| Teva Pharmaceuticals USA, Inc. | 50 | $710 |
| Lundbeck LLC | 47 | $677 |
| Johnson & Johnson | 40 | $631 |
| Alkermes, Inc. | 31 | $581 |
| Sunovion Pharmaceuticals Inc. | 30 | $479 |
| Indivior Inc. | 12 | $180 |
| Axsome Therapeutics, Inc. | 8 | $151 |
| Noven Therapeutics, LLC | 8 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $135 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Eisai Inc. | 6 | $76 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Integra Lifesciences Corporation | 1 | $38 |
| Neuronetics, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
How this compares
$9,376 in reported general payments places this provider in the 90th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 92 | $684,836 |
| Invega SustennaPaliperidone Palmitate | 129 | $435,327 |
| Abilify MaintenaAripiprazole | 48 | $141,434 |
| IngrezzaValbenazine Tosylate | 16 | $127,486 |
| VraylarCariprazine Hcl | 82 | $116,132 |
| FanaptIloperidone | 35 | $79,590 |
| TrintellixVortioxetine Hydrobromide | 95 | $57,541 |
| RexultiBrexpiprazole | 31 | $51,642 |
| CaplytaLumateperone Tosylate | 24 | $39,463 |
| PerserisRisperidone | 13 | $38,919 |
| SpravatoEsketamine Hcl | 22 | $26,244 |
| LybalviOlanzapine/Samidorphan Malate | 15 | $24,325 |
| BelsomraSuvorexant | 51 | $22,918 |
| Paliperidone ErPaliperidone | 28 | $14,969 |
| Clozapine | 185 | $13,810 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $710 | $684,83692 claims |
| Johnson & JohnsonInvega Sustenna, Spravato | $631 | $461,570151 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,062 | $193,07679 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,046 | $127,48616 claims |
| AbbVieVraylar | $1,233 | $116,13282 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $921 | $79,59035 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $135 | $62,566108 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,135 | $39,46324 claims |
| Indivior Inc.Perseris | $180 | $38,91913 claims |
| Alkermes, Inc.Lybalvi | $581 | $24,32515 claims |
| Eisai Inc.Dayvigo | $76 | $4,81815 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $2,390254 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Jeffersonville
- Eric JaggersJeffersonville$260K
- Geoffrey JeyasinghamJeffersonville$6K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.